What is ErSO for breast cancer? The drug, dubbed ErSO, works by over-activating a normally tumor-protective pathway to make it toxic for cancer cells. It eradicated both primary and metastatic tumors in mouse models of estrogen receptor-positive breast cancers, according to results published in Science Translational Medicine.
What is the new drug for HER2-positive breast cancer? Trastuzumab Deruxtecan Improves Progression-Free Survival, Shrinks More Tumors. The DESTINY-Breast03 trial enrolled 524 people with HER2-positive breast cancer that could not be removed by surgery or had metastasized to other parts of the body, including the brain.
Where does HER2 breast cancer usually spread to? Usually in HER2-positive metastatic breast cancer, common places of spread include the liver, lung, bones, lymph nodes, and unfortunately the brain.
What causes Reoccured breast cancer? Risk factors
For breast cancer survivors, factors that increase the risk of a recurrence include: Lymph node involvement. Finding cancer in nearby lymph nodes at the time of your original diagnosis increases your risk of the cancer coming back. Larger tumor size.